FDA Inspection
Hagop M. Kantarjian, M.D.Hagop M. Kantarjian, M.D. – FDA Inspection, Sep 16, 2011
Record Details
This FDA Inspection record concerns Hagop M. Kantarjian, M.D., with an inspection on September 16, 2011, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Hagop M. Kantarjian, M.D.
- Inspection Date
- September 16, 2011
- Product Type
- Drugs
View Company Profile
ID · 28ae3d8d-9664-418a-b943-68907bf72f9e
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 746460
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
FDA Citations
3- 21 CFR 312.60FD-1572, protocol compliance
- 21 CFR 312.62(b)Case history records- inadequate or inadequate
- 21 CFR 312.66Changes in research
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Hagop M. Kantarjian, M.D.
4| Date | Classification | Office | Project area |
|---|---|---|---|
| March 16, 2018 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| May 5, 2017 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| September 17, 2014 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| September 11, 2014 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Hagop M. Kantarjian, M.D.
- FDA Inspection 1048237 - 2018-03-16
- FDA Inspection 1029979 - 2017-05-05
- FDA Inspection 898289 - 2014-09-17
- FDA Inspection 896497 - 2014-09-11
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.